jay s wunder
jay s wunder
sinai health system, university of toronto, canada
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
B O'Sullivan, AM Davis, R Turcotte, R Bell, C Catton, P Chabot, J Wunder, ...
The Lancet 359 (9325), 2235-2241, 2002
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
KE Noonan, C Beck, TA Holzmayer, JE Chin, JS Wunder, IL Andrulis, ...
Proceedings of the National Academy of Sciences 87 (18), 7160-7164, 1990
Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma
AM Davis, B O'Sullivan, R Turcotte, R Bell, C Catton, P Chabot, J Wunder, ...
Radiotherapy and oncology 75 (1), 48-53, 2005
Detectable clonal mosaicism and its relationship to aging and cancer
KB Jacobs, M Yeager, W Zhou, S Wacholder, Z Wang, ...
Nature genetics 44 (6), 651-658, 2012
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
E De Alava, A Kawai, JH Healey, I Fligman, PA Meyers, AG Huvos, ...
Journal of Clinical Oncology 16 (4), 1248-1255, 1998
Treatment of giant-cell tumors of long bones with curettage and bone-grafting
HR Blackley, JS Wunder, AM Davis, LM White, R Kandel, RS Bell
JBJS 81 (6), 811-20, 1999
Giant cell tumor of long bone: a Canadian Sarcoma Group study
RE Turcotte, JS Wunder, MH Isler, RS Bell, N Schachar, BA Masri, ...
Clinical Orthopaedics and Related Research® 397, 248-258, 2002
Chordoma: long-term follow-up after radical photon irradiation
C Catton, B O'Sullivan, R Bell, N Laperriere, B Cummings, V Fornasier, ...
Radiotherapy and Oncology 41 (1), 67-72, 1996
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft …
D Callegaro, R Miceli, S Bonvalot, P Ferguson, DC Strauss, A Levy, ...
The Lancet Oncology 17 (5), 671-680, 2016
Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)
S Tejpar, F Nollet, C Li, JS Wunder, G Michils, P dal Cin, E Van Cutsem, ...
Oncogene 18 (47), 6615-6620, 1999
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape
C Lu, SU Jain, D Hoelper, D Bechet, RC Molden, L Ran, D Murphy, ...
Science 352 (6287), 844-849, 2016
Residual disease following unplanned excision of a soft-tissue sarcoma of an extremity
S Noria, A Davis, R Kandel, J Levesque, B O'SULLIVAN, JAY Wunder, ...
JBJS 78 (5), 650, 1996
Side population cells isolated from mesenchymal neoplasms have tumor initiating potential
C Wu, Q Wei, V Utomo, P Nadesan, H Whetstone, R Kandel, JS Wunder, ...
Cancer research 67 (17), 8216-8222, 2007
Cartilage tumours and bone development: molecular pathology and possible therapeutic targets
JVMG Bovée, PCW Hogendoorn, JS Wunder, BA Alman
Nature Reviews Cancer 10 (7), 481-488, 2010
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma
AM Davis, B O’sullivan, RS Bell, R Turcotte, CN Catton, JS Wunder, ...
Journal of clinical oncology 20 (22), 4472-4477, 2002
The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma
JS Wunder, G Paulian, AG Huvos, G Heller, PA MEYERS, JH HEALEY
JBJS 80 (7), 1020-33, 1998
Phase 2 study of preoperative image‐guided intensity‐modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma
B O'Sullivan, AM Griffin, CI Dickie, MB Sharpe, PWM Chung, CN Catton, ...
Cancer 119 (10), 1878-1884, 2013
Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: a matched case-control study
AM Davis, M Devlin, AM Griffin, JS Wunder, RS Bell
Archives of physical medicine and rehabilitation 80 (6), 615-618, 1999
Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone
P Rutkowski, S Ferrari, RJ Grimer, PD Stalley, SPD Dijkstra, A Pienkowski, ...
Annals of surgical oncology 22, 2860-2868, 2015
Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis
WY Chen, TK Cooper, CA Zahnow, M Overholtzer, Z Zhao, M Ladanyi, ...
Cancer Cell 6 (4), 387-398, 2004
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20